KeyBanc maintains Darden stock rating ahead of mixed quarter By Investing.com

KeyBanc reiterated an Overweight on Darden with a $225 price target while lowering its fiscal Q3 EPS to $2.92 (consensus $2.95), forecasting Olive Garden comps +3.3% (consensus 4.4%) and LongHorn comps +6.5% (consensus 5.7%). Darden reported fiscal Q2 adjusted EPS $2.08 (consensus $2.10) and sales $3.102B (consensus $3.076B); the company is ~$23.22B market cap, P/E 20.8, LTM diluted EPS $9.55. Analysts show a mixed but constructive stance—Mizuho raised its PT to $195, UBS maintained Buy with a $230 PT, and Stifel reiterated Buy—while Darden is closing 14 Bahama Breeze locations and converting 14 others, signaling near-term headwinds but medium/long-term confidence.

Analysis

Darden’s portfolio pruning and brand redeployment (asset-light conversions and closures) is a lever that often materializes as second-order margin expansion rather than immediate top-line growth; think SKU rationalization, concentrated protein buys, and lower marketing spend per unit where scale exists. That dynamic benefits broadline food distributors and high-utilization supply contracts, and simultaneously raises the opportunity cost for smaller, standalone casual concepts that lose corporate support or capital.

Near term, the key market sensitivities are earnings comps and consumer discretionary elasticity: traffic shocks or a step-up in discounting will show up within earnings prints and same-store metrics over the next 1–3 quarters, while the structural benefits of portfolio reshaping play out over 6–18 months. Tail risks include an outsized commodity or wage shock that erodes the newly realized unit economics, and an execution misstep on brand conversions that creates churn rather than consolidation.

Consensus appears to underweight the optionality inherent in converting marginal locations into higher-return formats and the short-to-medium-term free cash flow boost from lower maintenance capex; that’s the asymmetric payoff to own. Tactical positioning should express a medium-term tilt to the re-rating pathway while protecting against earnings-period volatility and downside macro surprises.

Key Decisions for Investors

• Long DRI (equity) — 6–12 month horizon. Size 1–2% NAV, target +25% if portfolio rationalization and margin expansion continue; hard stop -12% to limit downside from an earnings shock.
• Pair trade: Long DRI / Short EAT (equal notional) — 3–6 month horizon. Expresses conviction in scale/format optionality vs smaller casual peers. Target relative outperformance of 10–15%; cut if pair underperforms by 8% to preserve capital.
• Options: Buy a 6–9 month DRI call spread (buy ATM, sell 1.3–1.5x call) sized small (0.5–1% NAV). Max loss = premium; objective ~2:1 upside if market re-rates on better-than-feared margins. Use this to capture optionality while capping earnings-period vega risk.